Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Farmstandart OAO transfers Bever Pharmaceutical to OTCPharm-Interfax


Tuesday, 18 Feb 2014 09:25pm EST 

Farmstandart OAO:Pharmstandard has transferred Singapore-based Bever Pharmaceutical (Bever) to OTCPharm, into which it has spun off its non-prescription drugs business, OTCPharm materials show-Interfax.OTCPharm took possession of 100 percent of Bever, which holds a long-term contract with the producer of substances for manufacturing Arbidol and Afobazol, on Feb. 18.Earlier in Feb., Pharmstandard transferred 100 percent of Vindekspharm, which owns the rights to the Aciphol brand, and 99.93 percent of Donelle Company, which owns 100 percent of CJSC Afopharm, the owner of the rights to the Afobazol brand to OTCPharm. 

Company Quote

44.0
-0.5 -1.12%
4:55am EDT